A0A1X3J8J8 (A0A1X3J8J8_ECOLX) Escherichia coli H386
Beta-lactamase UniProtKBInterProInteractive Modelling
It is possible new templates exist for this target since these models were created.
However, an attempt to improve models for this target was made on 2024-12-17. The outcome - model was found to have problems. Please contact us to find out more.
Available Structures
121 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| PKS domains-fused AmpC EC2 |
Heteromer A7Z471; A7Z472; P00811; | 97.2 | ||||
| Crystal structure of AmpC beta-lactamase in complex with covalently bound N-formyl 7-aminocephalosp… | homo-2-mer | 100.0 | 2×2TV; 1×PO4; | |||
| X-ray crystal structure of the extended-spectrum AmpC E219K mutant beta-lactamase at 1.84 Angstrom … | homo-2-mer | 99.72 | 2×PO4; | |||
| AmpC beta-lactamase in complex with a p.carboxyphenylboronic acid | homo-2-mer | 100 | 2×C9P; | |||
| AmpC beta-lactamase in complex with 5-diformylaminomethyl-benzo[b]thiophen-2-boronic acid | homo-2-mer | 100 | 2×VA1; | |||
| AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR, BENZO(B)THIOPHENE-2-BORONIC ACID (BZB) | homo-2-mer | 100 | 2×BZB; | |||
| AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CLOXACILLINBORONIC ACID | homo-2-mer | 100 | 1×PO4; 2×105; | |||
| AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CEPHALOTHINBORONIC ACID | homo-2-mer | 100 | 1×PO4; 2×CTB; | |||
| AMPC BETA-LACTAMASE FROM ESCHERICHIA COLI | homo-2-mer | 100 | ||||
| Class C beta-lactamase from Escherichia coli | monomer | 98.61 | 4×EDO; | |||
| class C beta-lactamase from Escherichia coli in complex with cephalothin | monomer | 98.61 | 5×EDO; 1×9EP; | |||
| AmpC beta-lactamase N289A mutant in complex with a boronic acid deacylation transition state analog… | monomer | 99.72 | 1×K; 1×SM3; | |||
| AmpC beta-lactamase in complex with 4-Methanesulfonylamino benzoic acid | monomer | 100 | 1×GLC; 1×PO4; 3×4MB; | |||
| Crystal structure of AmpC from E.coli with Zidebactam (WCK 5107) | monomer | 100 | 1×PEG; 1×C8V; 1×ZN; 1×CL; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 5 (N-{[3-(2-chlorophenyl)-5-methy… | monomer | 100 | 1×1U3; 3×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 50 (N-(methylsulfonyl)-N-phenyl-a… | monomer | 100 | 3×NZ2; 1×NZ3; | |||
| Crystal structure of AmpC beta-lactamase in complex with the product form of 7-amino-desacetoxyceph… | monomer | 100.0 | 2×PO4; | |||
| Structure of N289A mutant of AmpC in complex with SM3, a phenylglyclboronic acid bearing the cephal… | monomer | 99.72 | 1×PO4; 1×K; 1×SM3; | |||
| Crystal structure of AmpC from E. coli with Taniborbactam (VNRX-5133) | monomer | 100 | 1×KJK; 1×MES; 1×PEG; 3×EDO; 1×K9K; 2×ZN; 3×CL; 1×NA; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 60 (2-[(propylsulfonyl)amino]benz… | monomer | 100 | 3×PO4; | |||
| AmpC beta-lactamase in complex with (3,5-di-tert-butylphenyl) boronic acid | monomer | 100.0 | 1×25N; 1×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with a designed 4-tetrazolyl pyridine sulfonami… | monomer | 100 | 1×0NA; 2×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 16 ((1R,4S)-4,7,7-trimethyl-3-oxo… | monomer | 100 | 1×1U5; 1×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with a 3-chloro-4-tetrazolyl benzene sulfonamid… | monomer | 100 | 1×0NB; 4×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with a 2-chloro-4-tetrazolyl benzene sulfonamid… | monomer | 100 | 2×0ND; | |||
| Crystal structure of AmpC from E.coli with Nacubactam (OP0595) | monomer | 100 | 1×MES; 1×OP0; 2×ZN; 1×SO4; 1×PGE; 1×CL; | |||
| Crystal structure of AmpC beta-lactamase in complex with the product form of (6R,7R)-7-amino-8-oxo-… | monomer | 100.0 | 1×2UZ; 2×PO4; | |||
| Structure of N289A mutant of AmpC in complex with SM2, carboxyphenylglycylboronic acid bearing the … | monomer | 99.72 | 1×PO4; 1×K; 1×SM2; | |||
| Crystal structure of AmpC beta-lactamase in complex with a 2-trifluoromethyl-4-tetrazolyl benzene s… | monomer | 100 | 1×0NE; 1×PO4; | |||
| AmpC beta-lactamase in complex with 2-acetamidothiophene-3-carboxylic acid | monomer | 100 | 2×F12; | |||
| AmpC K67R mutant apo structure | monomer | 99.72 | 2×PO4; | |||
| X-ray crystal structure of AmpC beta-lactamase with inhibitor | monomer | 100 | 1×H7D; | |||
| Crystal structure of AmpC from E.coli | monomer | 100 | 1×EDO; 2×ZN; 1×SO4; 1×CL; | |||
| X-ray Crystal Structure of AmpC S64G Mutant beta-Lactamase | monomer | 99.72 | 1×GLC; 2×PO4; | |||
| Crystal structure of AmpC from E.coli with Avibactam | monomer | 100 | 1×PGE; 1×NXL; 2×ZN; 1×CL; | |||
| X-ray Crystal Structure of AmpC S64G Mutant beta-Lactamase in Complex with Substrate and Product Fo… | monomer | 99.72 | 2×PO4; 1×KCP; 1×CLS; | |||
| X-ray Crystal Structure of AmpC S64D Mutant beta-Lactamase | monomer | 99.72 | 1×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with a small chloromethyl sulfonamide boronic a… | monomer | 100 | 1×0NG; 2×PO4; | |||
| Crystal structure of AmpC from E. coli with Cyclic Boronate 3 (CB3 / APC308) | monomer | 100 | 1×KL8; 2×PEG; 1×DMS; 2×EDO; 1×CL; 1×ZN; | |||
| Crystal structure of AmpC beta-lactamase in complex with a designed 3-carboxyl benzyl sulfonamide b… | monomer | 100 | 1×0N3; 3×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 48 (3-(cyclopropylsulfamoyl)thiop… | monomer | 100 | 5×NZ9; 1×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with a sulfonamide boronic acid inhibitor | monomer | 100.0 | 1×BSF; 1×PO4; | |||
| X-ray crystal structure of the extended-spectrum AmpC E219K mutant beta-lactamase complexed with be… | monomer | 99.72 | 1×PO4; 1×BZB; | |||
| Crystal structure of AmpC beta-lactamase in complex with a sulfonamide boronic acid inhibitor | monomer | 100 | 1×BSH; 1×PO4; | |||
| X-ray crystal structure of the extended-spectrum AmpC omega loop insertion (H210AAA) mutant beta-la… | monomer | 100.0 | 1×PO4; | |||
| Crystal Structure of AmpC beta-lactamase from E. coli in Complex with Oxacillin | monomer | 100 | 1×1S6; 1×PO4; | |||
| AmpC beta-lactamase in complex with [1-(6-chloropyrimidin-4-yl)-1H-pyrazol-4-yl] boronic acid | monomer | 100 | 1×N95; 1×PO4; | |||
| AmpC beta-lactamase in complex with m-aminophenyl boronic acid | monomer | 100 | 1×APB; 1×PO4; | |||
| X-ray Crystal Structure of AmpC N152H Mutant beta-Lactamase | monomer | 99.72 | 2×PO4; | |||
| X-ray crystal structure of AmpC beta-lactamase with inhibitor | monomer | 100.0 | 1×A1AUT; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 44 (5-chloro-3-sulfamoylthiophene… | monomer | 100 | 1×1U1; 1×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 13 ((2R,6R)-6-methyl-1-(3-sulfany… | monomer | 100 | 4×PO4; | |||
| X-ray crystal structure of AmpC beta-lactamase with inhibitor | monomer | 100.0 | 1×A1AU1; | |||
| Crystal Structure of the complex between Q120L/Y150E mutant of AmpC and a beta-lactam inhibitor (MX… | monomer | 99.44 | 1×K; 1×MXG; | |||
| Crystal structure of AmpC from E.coli with Relebactam (MK-7655) | monomer | 100 | 1×PEG; 1×MK7; 2×ZN; 1×MES; 2×SO4; 1×CL; | |||
| Crystal Structure Of AmpC beta-Lactamase From E. Coli In Complex With ATMO-penicillin | monomer | 100 | ||||
| AmpC beta-lactamase in complex with an M.carboxyphenylglycylboronic acid bearing the cephalothin R1… | monomer | 100 | 1×PO4; 1×SM3; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 41 ((4R,4aS,8aS)-4-phenyldecahydr… | monomer | 100.0 | 3×PO4; 1×1U7; | |||
| X-ray crystal structure of AmpC beta-lactamase from E. coli | monomer | 100.0 | 2×PO4; | |||
| AmpC beta-lactamase in complex with [1-(3-chlorophenyl)-1H-pyrazol-4-yl] boronic acid | monomer | 100 | 2×NL9; 2×PO4; | |||
| Crystal Structure of AmpC beta-lactamase N152G Mutant from E. coli | monomer | 99.72 | 2×PO4; | |||
| Crystal structure of AmpC from E.coli with Enmetazobactam (AAI-101) | monomer | 100 | 1×SO4; 2×PEG; 1×M9W; 3×ZN; 1×CL; | |||
| X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a non-covalent inhibito… | monomer | 100 | 1×1MU; 1×PO4; | |||
| Crystal structure of AmpC beta-lactamase in complex with a sulfonamide boronic acid inhibitor | monomer | 100.0 | 1×BSG; 1×PO4; | |||
| X-ray crystal structure of AmpC beta-lactamase with nanomolar inhibitor | monomer | 100 | 1×H7M; | |||
| Crystal structure of AmpC beta-lactamase in complex with a designed 4-tetrazolyl benzene sulfonamid… | monomer | 100.0 | 1×0N4; 1×PO4; | |||
| AmpC beta-lactamase in complex with Fragment-based Inhibitor | monomer | 100 | 2×DMS; 1×GF7; | |||
| AmpC beta-lactamase in complex with Fragment-based Inhibitor | monomer | 100 | 1×GF4; | |||
| AmpC beta-lactamase in complex with Fragment-based Inhibitor | monomer | 100 | 3×GV9; 1×PO4; 1×PEG; | |||
| AmpC beta-lactamase with bound Phthalamide inhibitor | monomer | 100 | 5×PO4; 1×23C; | |||
| AmpC beta-lactamase in complex with Fragment-based Inhibitor | monomer | 100 | 4×PO4; 1×3GV; 1×DMS; | |||
| X-ray crystal structure of AmpC WT beta-lactamase in complex with covalently bound imipenem | monomer | 100.0 | 1×IM2; | |||
| Structure of AmpC beta-lactamase with cross-linked active site after exposure to small molecule inh… | monomer | 100.0 | ||||
| AmpC beta-lactamase in complex with an m.carboxyphenylglycylboronic acid bearing the cephalothin R1… | monomer | 100 | 1×PO4; 1×SM2; | |||
| CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE MUTANT N152A COVALENTLY ACYLATED WITH THE INHI… | monomer | 99.72 | 1×MOX; | |||
| AmpC K67R mutant complexed with benzo(b)thiophene-2-boronic acid (bzb) | monomer | 99.72 | 1×BZB; 1×PO4; | |||
| AmpC beta-lactamase with bound Phthalamide inhibitor | monomer | 100 | 1×PO4; 1×DK2; | |||
| Crystal Structure Of AmpC beta-Lactamase From E. Coli In Complex With Amoxicillin | monomer | 100 | ||||
| X-ray crystal structure of AmpC beta-lactamase with inhibitor | monomer | 100 | 1×A1AU5; | |||
| Crystal Structure of AmpC beta-lactamase from E. coli in Complex with Cefotaxime | monomer | 100 | 1×PO4; 1×CEF; | |||
| Crystal Structure of AmpC beta-lactamase N152G Mutant in Complex with Cefoxitin | monomer | 99.72 | 2×PO4; 1×1S7; | |||
| AmpC beta-lactamase in complex with Fragment-based Inhibitor | monomer | 100 | 2×PO4; 2×GTC; | |||
| AmpC beta-lactamase with bound Phthalamide inhibitor | monomer | 100 | 4×PO4; 1×WH6; 1×DMS; | |||
| X-ray Crystal Structure of AmpC K67Q Mutant beta-Lactamase | monomer | 99.72 | 1×PO4; | |||
| The crystal structure of a Beta-lactamase from Escherichia coli CFT073 | monomer | 98.6 | 4×GOL; 2×SO4; | |||
| X-ray crystal structure of AmpC beta-lactamase with inhibitor | monomer | 100 | 1×H7G; | |||
| X-ray crystal structure of the extended-spectrum AmpC Y221G mutant beta-lactamase at 1.90 Angstrom … | monomer | 99.72 | 1×GLC; 1×PO4; | |||
| X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a non-covalent inhibito… | monomer | 100.0 | 2×PO4; | |||
| X-ray crystal structure of AmpC beta-lactamase with inhibitor | monomer | 100 | 1×H7A; | |||
| X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a DOCK-predicted non-co… | monomer | 100.0 | 1×STC; | |||
| AmpC beta-lactamase in complex with 3-(3-nitro-phenylsulfamoyl)-thiophene-2-carboxylic acid | monomer | 100.0 | ||||
| AmpC beta-lactamase in complex with 3-(4-carboxy-2-hydroxy-phenylsulfamoyl)-thiophene-2-carboxylic … | monomer | 100.0 | 1×HTC; | |||
| AmpC beta-lacamase with bound covalent oxadiazole inhibitor | monomer | 100 | 1×DMS; 1×OX6; | |||
| AmpC Beta-lactamase in complex with (1R)-1-(2-Thiophen-2-yl-acetylamino)-1-(3-(2-carboxyvinyl)-phen… | monomer | 100 | 1×SM4; 2×PO4; | |||
| Crystal Structure of AmpC beta-lactamase from E. coli in Complex with Ceftazidime | monomer | 100.0 | 1×PO4; 1×CAZ; | |||
| Crystal structure of AmpC from E. coli with cyclic boronate 2 | monomer | 100 | 1×OK3; 1×MPD; 1×EPE; 1×NA; 1×CL; | |||
| X-ray Crystal Structure of AmpC WT beta-Lactamase in Complex with Covalently Bound Cephalothin | monomer | 100.0 | 1×PO4; | |||
| AmpC beta-lactamase in complex with Fragment-based Inhibitor | monomer | 100 | 4×PO4; 2×DMS; 2×GF1; | |||
| CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH NON-BETA-LACTAMASE INHIBITOR (… | monomer | 100 | 2×PO4; 1×ETP; | |||
| AmpC beta-lactamase in complex with 2-carboxythiophene | monomer | 100 | 6×C21; | |||
| Crystal Structure of AmpC beta-lactamase N152G Mutant in Complex with Cefotaxime | monomer | 99.72 | 3×PO4; 1×CEF; | |||
| X-ray crystal structure of the extended-spectrum AmpC T70I mutant beta-lactamase with and without b… | monomer | 99.69 | ||||
| X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with the inhibitor 3-nitroph… | monomer | 100 | 1×NPB; | |||
| X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with the inhibitor 4,4'-biph… | monomer | 100 | 1×PO4; 1×BDB; | |||
| CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE COVALENTLY ACYLATED WITH THE INHIBITORY BETA-L… | monomer | 100.0 | 1×MOX; | |||
| AmpC beta-lactamase in complex with 4-Amino-3-hydroxybenzoic acid | monomer | 100.0 | 1×PO4; 8×4A3; | |||
| X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with the inhibitor 4-carboxy… | monomer | 100 | 1×PO4; 1×4CB; | |||
| Crystal structure of AmpC beta-lactamase in complex with fragment 20 (1,3-diethyl-2-thioxodihydropy… | monomer | 100 | 2×1U6; 1×PO4; | |||
| X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with the inhibitor 4-(carbox… | monomer | 100 | 1×PO4; 1×CVB; | |||
| X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a non-covalent inhibito… | monomer | 100 | 1×1MW; 1×PO4; | |||
| X-ray crystal structure of the extended-spectrum AmpC Y221G mutant beta-lactamase in complex with c… | monomer | 99.72 | ||||
| Crystal Structure of AmpC beta-lactamase from E. coli in Complex with a Boronic Acid Inhibitor (1, … | monomer | 100 | 1×PO4; 1×CB4; | |||
| Crystal Structure of the E. Coli AMPC Beta-Lactamase Mutant Q120L/Y150E Covalently Acylated with th… | monomer | 99.43 | 1×LOR; | |||
| CRYSTAL STRUCTURE OF THE E.COLI AMPC BETA-LACTAMASE MUTANT Q120L/Y150E COVALENTLY ACYLATED WITH THE… | monomer | 99.43 | 1×CXU; | |||
| AmpC beta-lactamase in complex with Fragment-based Inhibitor | monomer | 100.0 | 3×PO4; 2×G14; 1×PEG; | |||
| X-ray crystal structure of the extended-spectrum AmpC V298E mutant beta-lactamase at 2.64 Angstrom … | monomer | 99.71 | 3×SO4; | |||
| X-ray crystal structure of AmpC beta-lactamase with inhibitor | monomer | 100.0 | 1×A1AUZ; | |||
| X-ray crystal structure of AmpC beta-lactamase with inhibitor | monomer | 100 | 1×A1AU0; | |||
| Crystal structure of the S61A mutant of AmpC BER | monomer | 97.12 | 2×CIT; | |||
| AMPC BETA-LACTAMASE FROM ESCHERICHIA COLI | monomer | 100 | 1×APB; | |||
| Class C beta-lactamase from Escherichia coli in complex with Tazobactam | monomer | 98.6 | 1×TBE; 2×EDO; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1my8.1.A | monomer | 0.91 | 100.00 | |||